Zynex Medical appoints two to board of directors

Tuesday January 16, 2018 0 comments Tags: Lone Tree, Zynex, Michael Cress, Barry Michaels, Thomas Sandgaard

LONE TREE -- Zynex, Inc. (OTCQB: ZYXI), a medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced the appointment of Michael Cress and Barry Michaels to its board of directors and audit committee.Zynex_logoUSE 

Michaels will also serve as audit committee chair.

"I am very pleased with the appointment of our two new independent board members,” said Thomas Sandgaard, Zynex founder, chair and CEO.

“Their business and healthcare industry experience will provide us the depth and resources required for the company to continue on its growth trajectory as well as complying with the requirements of a senior exchange."

Cress serves as chair and managing partner of MD Cress Ventures, a national firm that owns, operates and advises companies in the healthcare sector. He also serves as chair of Rainier Healthcare. 

Prior to MD Cress Ventures, he served as president and CEO of Cornerstone Healthcare Group, which owns and manages hospitals throughout the country. He also served as VP of business development for Kindred Healthcare, a publicly traded healthcare company that owns and operates hospitals, nursing homes, rehabilitation, pharmacy and other segments of the healthcare continuum.

Cress served as CEO of Vencor Hospital of San Diego and was also an adjunct professor for the Masters of Healthcare Administration program at the University of Kansas. He serves on several not-for-profit boards and co-founded and serves on the board for The Neighborhood.  

He also serves on the boards or advisory boards of several companies, including Linley Capital, BankSNB, Rainier Hospice and Sleep Research.

Michaels has 40 years of financial and general management experience in the medical device and biotechnology industries with industry leaders including Medtronic, Johnson & Johnson, and Baxter Healthcare, as well as having served as president or CFO of seven emerging stage companies.

Most recently, Michaels served as a consultant to Organovo Holdings, Inc. after retiring from there in 2016, where he served as CFO since 2011. 

Michaels received an MBA with a concentration in finance from San Diego State University and is a graduate of the Executive Program at the UCLA Anderson Graduate School of Management.